MegatrendsMegatrends: not the usual suspects, but who actually profits.View megatrends →

Metrics as of 10/13/2026, 06:50 PM (Berlin time), refresh in progress.

Talkspace Stock

Talkspace, Inc.

TALKNASDAQMarkt
US$5.25
+0.0% today

Company data

Sector
Healthcare
Industry
Medical - Care Facilities
Country
United States
CEO
Jon R. Cohen
Employees
598
Market cap
$879 M
IPO
30/07/2020

Providing virtual behavioral healthcare services, Talkspace, Inc. operates a digital platform accessible via secure web and mobile applications. It offers a wide array of treatment options, including psychiatry, adolescent counseling, individual therapy, and support for couples. Clients can communicate with their…

Talkspace stock: price history

18/08/25+101.9 %18/08/26

1D

+0.0%

1W

+0.2%

1M

+0.8%

6M

+37.1%

YTD

+44.6%

1Y

+101.9%

2Y

+198.3%

5Y

-0.2%

10Y

–

Next earnings date

Next earnings date

29/10/2026 (in 12 days)

Volatility around earnings

~79% stronger price swings than usual

Ask the agents about Talkspace

Analyst assessment of Talkspace

PRICE TARGET LOW

US$2.00

CONSENSUS

US$4.38

MEDIAN

US$5.13

PRICE TARGET HIGH

US$5.25

0

STRONG BUY

2

BUY

8

HOLD

0

SELL

0

STRONG SELL

10

TOTAL · Hold

As of: 10/03/2026

ANALYST FIRMRATINGACTIONDATE
KeybancOverweight → Sector Weightdowngrade10/03/2026
BarclaysEqual Weightmaintain10/03/2026
Canaccord GenuityBuy → Holddowngrade09/03/2026
NeedhamBuy → Holddowngrade09/03/2026
TD CowenBuymaintain20/02/2026
NeedhamBuymaintain19/02/2026
KeybancOverweightmaintain08/01/2026
NeedhamBuymaintain02/12/2025

Talkspace stock metrics

P/E

-4,375

P/B

7.84

EV/EBITDA

176.46

RETURN ON EQUITY

-1.4%

NET MARGIN

-2.5%

DEBT/EQUITY

0

DIVIDEND YIELD

0.0%

AS OF

30/06/2026

Free float & liquidity

FREE FLOAT

77.4%

FLOAT SHARES

129,629,599

AVG. DAILY VOLUME (30D)

1,660,223

Insider transactions (SEC)

ROLETRANSACTIONSHARESPRICEPLAN TYPEDATE

Harris Ian Jiro

OfficerReturn to issuer420,824–Spontaneous17/08/2026

Pawar Madhu

DirectorReturn to issuer48,222–Spontaneous17/08/2026

Benzur Liat

DirectorReturn to issuer77,446–Spontaneous17/08/2026

Benzur Liat

DirectorReturn to issuer78,830–Spontaneous17/08/2026

Abbott Swati Bargotra

DirectorReturn to issuer92,866–Spontaneous17/08/2026
Page 1 / 9

Attention

1 mention today in US forums, about the same as yesterdayPrice since yesterday: +0.0%

Forums (Reddit)

26/0810/0916/10

Institutional holders

FUND / INSTITUTIONSHARESCHANGEAS OF
Valeo Financial Advisors, LLC0-323,65730/09/2026
Farther Finance Advisors, LLC0-1630/09/2026
GAMMA Investing LLC0-28330/09/2026
BlackRock, Inc.11,260,345+853,68630/06/2026
Hudson Executive Capital LP9,795,600-1,545,00030/06/2026
Page 1 / 3

Comparable stocks

Frequently asked questions about Talkspace stock

What does Talkspace do?

Talkspace, Inc. is a company in the Healthcare sector, Medical - Care Facilities industry, headquartered in United States.

The CEO is Jon R. Cohen, the company employs around 598 people.

The IPO was on 30/07/2020; the stock trades on NASDAQ under the ticker TALK.

What do analysts say about Talkspace stock?

10 analysts rate the stock, the consensus is Hold (as of 10/03/2026).

The average price target is US$4.38, ranging from US$2.00 to US$5.25, with a median of US$5.13.

This is an external assessment, not a statement by Market Jury.

When does Talkspace report next?

The next earnings date is 29/10/2026.

Around past earnings, price swings were roughly 79% stronger than usual.

Does Talkspace pay a dividend?

No, Talkspace currently does not pay a dividend.

Which stocks are comparable to Talkspace?

Comparable stocks include HCA Healthcare, Tenet Healthcare, DaVita, Universal Health Services, Hims & Hers Health, LifeStance Health Group, Concentra Group Holdings Parent and Acadia Healthcare Company.

How can I get Talkspace stock analyzed?

Clicking "Analyze stock" lets five strategies assess Talkspace against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.

Not investment advice. Past performance is not an indicator of future results.